Method AI Secures $20M Series A for Surgical Oncology AI Platform

Method AI, a medical technology company, secured $20 million in Series A funding. A private family office led the round. This Method AI surgical AI platform will advance image-guided surgical navigation.

The platform emerged from Cleveland Clinic in 2021. It aims to improve oncology outcomes by resolving surgical visualization challenges for robotic surgeons. Cleveland Clinic and JobsOhio Growth Capital Fund also participated in the investment.

Method AI's novel surgical ultrasound technology visualizes anatomy deep below the surface. This capability extends beyond current surgical camera systems.

Furthermore, the Method AI surgical AI system generates a first-of-its-kind 3D subsurface map for physicians. It provides real-time guidance against an AI-generated surgical plan. This technology seeks to significantly improve cancer-free survival rates.

Up to 40% of surgeries currently fail to fully remove cancer. Surgeons often struggle to gauge tumor margins during complex procedures.

Advancing Image-Guided Surgical Navigation

Method AI's platform offers continuous 3D ultrasound imaging throughout procedures. Its real-time algorithms build maps of critical subsurface features. Machine learning then generates plans, guiding physicians to optimal surgical outcomes. Companies like Intuitive Surgical and Medtronic also innovate in this medical technology space.

The Boston-area company focuses on reimagining the surgical field of view. This AI in healthcare solution is currently under development. It is not yet cleared for commercial distribution.